Mei Bai

OverviewAI-generated summary

Mei Bai's research has investigated the therapeutic potential of natural compounds and their mechanisms of action in preclinical models. Recent work includes studies on the natural compound PEITC, examining its ability to suppress neutrophil extracellular traps and alleviate chemotherapeutic intestinal injury in mice, as well as its direct inhibition of GSDMD to reduce hepatocyte pyroptosis and acute liver injury. Bai has also studied the compound fraxinellone for its amelioration of intestinal fibrosis in mice by intervening in the HSP47-collagen interaction. Other research areas include the role of STAT3 in activating lncRNA NR2F1‐AS1 to promote melanoma progression and the association of Fc receptor-like variants with rheumatoid arthritis risk in the Chinese Han population. Bai also contributed to a systematic review on the psychological response to advanced cancer diagnosis and developed a dual-modality sensing probe for cobalt ion detection.

Metrics

• h-index: 18
• Publications: 76
• Citations: 1,350